Niagen Bioscience, Inc. (NAGE)

7.4 -0.02 (-0.27%)

As of 2025-10-16 17:26:21 EST

Niagen Bioscience (NASDAQ: NAGE), formerly ChromaDex, is a bioscience сompany based in Los Angeles, California founded in 1999. The company operates in multiple sectors including reference standards, dietary supplements, and ingredient technology. Niagen Bioscience is publicly traded on the NASDAQ.

Traded asNasdaq: NAGE
ISINUS1710774076
CIK0001386570
LEI—
EIN262940963
SectorDietary supplements
IndustryMedicinal Chemicals & Botanical Products
CEORob Fried
Employees—
Fiscal Year End1231
Address10900 WILSHIRE BLVD, LOS ANGELES, CA, 90024
Phone310-388-6706
Websitehttps://www.niagenbioscience.com/
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
NAGENiagen Bioscience, Inc.2025-10-16 17:26:217.4-0.02-0.27
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
NAGE0001386570Niagen Bioscience, Inc.US1710774076—262940963Nasdaq2833Medicinal Chemicals & Botanical Products1231DE10900 WILSHIRE BLVDLOS ANGELESCA90024UNITED STATESUS310-388-670610900 WILSHIRE BLVD, LOS ANGELES, CA, 9002410900 WILSHIRE BLVD, LOS ANGELES, CA, 90024ChromaDex Corp.Dietary supplements1999Rob Fried—https://www.niagenbioscience.com/142,700,00079,586,00079,752,957Niagen Bioscience (NASDAQ: NAGE), formerly ChromaDex, is a bioscience сompany based in Los Angeles, California founded in 1999. The company operates in multiple sectors including reference standards, dietary supplements, and ingredient technology. Niagen Bioscience is publicly traded on the NASDAQ.2025-10-10 21:23:32
This is a preview of the latest data. Subscribe to access the full data.
NAGE Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
NAGE Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
2024142,700,00061,600,00075.955677,750,4472,441,3293.2417
202381,100,0001,900,0002.39975,309,118470,6270.6289
202279,200,000-394,300,000-83.273574,838,4916,529,1269.5582
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
2024104
2023106
2022113
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202420232022
Revenue99,597,00083,570,00072,050,000
Cost Of Revenue38,011,00032,790,00029,253,000
Gross Profit61,586,00050,780,00042,797,000
Research And Development Expenses6,016,0004,958,0004,826,000
General And Administrative Expenses18,375,00024,983,00028,286,000
Operating Expenses53,860,00056,379,00061,425,000
Operating Income7,726,000-5,599,000-18,628,000
Net Income8,550,000-4,938,000-16,540,000
Earnings Per Share Basic0.11-0.07-0.24
Earnings Per Share Diluted0.11-0.07-0.24
Weighted Average Shares Outstanding Basic75,929,00074,985,00069,729,000
Weighted Average Shares Outstanding Diluted78,125,00074,985,00069,729,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202420232022
Cash And Cash Equivalents44,500,00027,200,00020,300,000
Marketable Securities Current———
Accounts Receivable02,800,0008,482,000
Inventories9,192,00014,525,00014,677,000
Non Trade Receivables———
Other Assets Current———
Total Assets Current64,102,00049,534,00046,567,000
Marketable Securities Non Current———
Property Plant And Equipment———
Other Assets Non Current368,000383,000497,000
Total Assets Non Current4,176,0005,430,0007,490,000
Total Assets68,278,00054,964,00054,057,000
Accounts Payable8,526,00010,232,0009,679,000
Deferred Revenue———
Short Term Debt———
Other Liabilities Current7,817,0009,493,0007,337,000
Total Liabilities Current17,948,00020,622,00017,869,000
Long Term Debt———
Other Liabilities Non Current———
Total Liabilities Non Current4,236,0005,886,0007,516,000
Total Liabilities22,184,00026,508,00025,385,000
Common Stock77,00075,00074,000
Retained Earnings-181,910,000-190,460,000-185,493,000
Accumulated Other Comprehensive Income———
Total Shareholders Equity46,094,00028,456,00028,672,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202420232022
Depreciation And Amortization663,000870,000869,000
Share Based Compensation Expense3,656,0004,751,0005,739,000
Other Non Cash Income Expense-80,000-75,000-67,000
Change In Accounts Receivable———
Change In Inventories-5,333,000-152,0001,076,000
Change In Non Trade Receivables1,279,000-2,255,0003,319,000
Change In Other Assets———
Change In Accounts Payable-1,067,000553,000-744,000
Change In Other Liabilities1,206,0002,156,000856,000
Cash From Operating Activities12,109,0007,117,000-15,098,000
Purchases Of Marketable Securities———
Sales Of Marketable Securities———
Acquisition Of Property Plant And Equipment———
Acquisition Of Business———
Other Investing Activities———
Cash From Investing Activities-143,000-143,000-334,000
Tax Withholding For Share Based Compensation———
Payments Of Dividends———
Issuance Of Common Stock—07,747,000
Repurchase Of Common Stock———
Issuance Of Long Term Debt———
Repayment Of Long Term Debt———
Other Financing Activities———
Cash From Financing Activities5,369,000-90,0007,654,000
Change In Cash17,335,0006,884,000-7,778,000
Cash At End Of Period44,500,00027,200,00020,300,000
Income Taxes Paid———
Interest Paid1,0002,0001,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202420232022
Earnings Per Share0.11-0.07-0.24
Price To Earnings Ratio48.2273-20.4286-7
Earnings Growth Rate-257.1429-70.8333-40
Price Earnings To Growth Ratio-0.18760.28840.175
Book Value Per Share0.60710.37950.4112
Price To Book Ratio8.73873.76824.0857
Ebitda9,213,000-3,407,000-15,668,000
Enterprise Value———
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio———
Capital Expenditures———
Free Cash Flow———
Return On Equity0.1855-0.1735-0.5769
One Year Beta1.0941.33921.6492
Three Year Beta1.49911.26260.9443
Five Year Beta0.98720.97670.9384
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Jaksch Frank L JrDirector2025-06-2420,000A20,000
Cohen AnnDirector2025-06-2420,000A20,000
Ng Wang Yu GaryDirector2025-06-2420,000A20,000
Rubin Steven DDirector2025-06-2420,000A20,000
Patrick KristinDirector2025-06-2420,000A20,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Precision Wealth Strategies, LLC2025-09-301,527,088163,6759.33
CWM, LLC2025-09-30246,00026,3589.333
BSW Wealth Partners2025-09-30793,05085,0009.33
Farther Finance Advisors, LLC2025-09-30140159.3333
Rise Advisors, LLC2025-09-30494539.3208
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
Advisors' Inner Circle Fund III2025-07-31I SharesKCXIX2982,786.30.0011
Global X Funds2025-07-31Global X Russell 2000 ETFRSSL26,612248,822.20.0189
PACE SELECT ADVISORS TRUST2025-07-31Class P2PAPTX4944,618.90.0017
PACE SELECT ADVISORS TRUST2025-07-31Class PPASPX4944,618.90.0017
PACE SELECT ADVISORS TRUST2025-07-31Class APASIX4944,618.90.0017
This is a preview of the latest data. Subscribe to access the full data.